Heron Therapeutics Inc vs Monolithic Power Systems Inc — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Monolithic Power Systems Inc trades at $1,441.01 (market cap $68.90B). The key difference: Monolithic Power Systems Inc is far larger — about 1120.9× Heron Therapeutics Inc's market cap, and Monolithic Power Systems Inc pays a 0.57% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | MPWR | |
|---|---|---|
Market Cap | $61.47M | $68.90B |
Sector | Health | Utilities |
52-Week High | $1.49 | $1.69K |
52-Week Low | $0.32 | $820.74 |
Enterprise Value | $168.21M | $67.51B |
Dividend Yield | — | 0.57% |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →